ATE499366T1 - 1-ä(6-substituiertes alkoxychinoxalinyl) - Google Patents

1-ä(6-substituiertes alkoxychinoxalinyl)

Info

Publication number
ATE499366T1
ATE499366T1 AT05809031T AT05809031T ATE499366T1 AT E499366 T1 ATE499366 T1 AT E499366T1 AT 05809031 T AT05809031 T AT 05809031T AT 05809031 T AT05809031 T AT 05809031T AT E499366 T1 ATE499366 T1 AT E499366T1
Authority
AT
Austria
Prior art keywords
substituted
alkoxychinoxalinyl
compounds
piperazine compounds
quioxaline
Prior art date
Application number
AT05809031T
Other languages
English (en)
Inventor
Young-Dae Gong
Moon-Kook Jeon
Dong-Su Kim
Jae Yang Kong
Gun-Do Kim
Chang-Ho Ahn
Young Bok Lee
Original Assignee
Rexahn Pharmaceuticals Inc
Korea Res Inst Chem Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36407350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE499366(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from KR1020040094233A external-priority patent/KR100739233B1/ko
Priority claimed from KR1020040094232A external-priority patent/KR20060053788A/ko
Application filed by Rexahn Pharmaceuticals Inc, Korea Res Inst Chem Tech filed Critical Rexahn Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE499366T1 publication Critical patent/ATE499366T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT05809031T 2004-11-17 2005-10-18 1-ä(6-substituiertes alkoxychinoxalinyl) ATE499366T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020040094233A KR100739233B1 (ko) 2004-11-17 2004-11-17 1-[(3-알콕시-6-치환-퀴녹살린-2-일)아미노카르보닐]-4-(헤테로)아릴피페라진 유도체
KR1020040094232A KR20060053788A (ko) 2004-11-17 2004-11-17 1-[(2-알콕시-6-치환-퀴녹살린-3-일)아미노카르보닐]-4-(헤테로)아릴피페라진 유도체
PCT/KR2005/003463 WO2006054830A1 (en) 2004-11-17 2005-10-18 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives

Publications (1)

Publication Number Publication Date
ATE499366T1 true ATE499366T1 (de) 2011-03-15

Family

ID=36407350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05809031T ATE499366T1 (de) 2004-11-17 2005-10-18 1-ä(6-substituiertes alkoxychinoxalinyl)

Country Status (12)

Country Link
US (2) US8314100B2 (de)
EP (1) EP1819698B1 (de)
JP (1) JP6097946B2 (de)
CN (1) CN103524436B (de)
AT (1) ATE499366T1 (de)
AU (1) AU2005307209B2 (de)
BR (1) BRPI0517734A (de)
CA (1) CA2587891C (de)
DE (1) DE602005026557D1 (de)
MX (1) MX2007005863A (de)
PL (1) PL1819698T3 (de)
WO (1) WO2006054830A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE499366T1 (de) 2004-11-17 2011-03-15 Rexahn Pharmaceuticals Inc 1-ä(6-substituiertes alkoxychinoxalinyl)
KR101140133B1 (ko) 2010-02-17 2012-05-02 한국화학연구원 1-(6,7-다이플루오르-3-메톡시퀴녹살린-2-일)-3-[1-(헤테로아릴메틸)피페리딘-4-일] 우레아 유도체, 그 제조방법 및 그의 용도
MX363378B (es) 2013-06-28 2019-03-21 Rexahn Pharmaceuticals Inc Composiciones nanoparticuladas y formulaciones de compuestos de piperazina.
PL3231800T3 (pl) 2014-12-08 2020-04-30 Lsk Nrdo Co., Ltd. Nowa pochodna 4-(arylo) -n-(2-alkoksytieno[3,2-b]pirazyn-3-ylo)-piperazyno-1-karboksyamidu oraz jej działanie antyproliferacyjne
KR20180049015A (ko) 2015-09-04 2018-05-10 렉산 파마슈티컬스, 인코포레이티드 퀴녹살리닐-피페라진아미드의 사용 방법
KR101872645B1 (ko) 2016-06-09 2018-08-03 동국대학교 산학협력단 신규한 4-(아릴)-N-(3-알콕시퓨로[2,3-b]피라진-2-일)-피페라진-1-카복스아미드 유도체 및 이의 항증식 효과
WO2017213452A1 (ko) * 2016-06-09 2017-12-14 동국대학교 산학협력단 신규한 4-(아릴)-n-(3-알콕시퓨로[2,3-b]피라진-2-일)-피페라진-1-카복스아미드 유도체 및 이의 항증식 효과

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59104A (en) * 1979-02-09 1984-02-29 Roussel Uclaf Heterotricyclic derivatives,process for their preparation and pharmaceutical compositions incorporating them
FR2448541A1 (fr) * 1979-02-09 1980-09-05 Roussel Uclaf Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
US6028184A (en) * 1996-12-31 2000-02-22 Max-Plank-Gesellschaft Zur Forderung Der Wissenschaften E.V. Pax6 and Pax4 nucleic acid mixtures
PL325341A1 (en) * 1996-06-29 1998-07-20 Samjin Pharmaceutical Co Derivatives od piperazine and method of obtaining them
AU763030B2 (en) 1999-03-03 2003-07-10 Samjin Pharmaceutical Co., Ltd. Piperazine derivatives and process for the preparation thereof
WO2001095856A2 (en) * 2000-06-15 2001-12-20 Chaconne Nsi Co., Ltd. Urea derivative useful as an anti-cancer agent and process for preparing same
AR043059A1 (es) 2002-11-12 2005-07-13 Bayer Pharmaceuticals Corp Derivados de indolil pirazinona utiles para el tratamiento de trastornos hiper-proliferativos
MXPA05011076A (es) 2003-04-16 2006-01-24 Astrazeneca Ab Derivados de quinazolina para el tratamiento de cancer.
ATE499366T1 (de) 2004-11-17 2011-03-15 Rexahn Pharmaceuticals Inc 1-ä(6-substituiertes alkoxychinoxalinyl)

Also Published As

Publication number Publication date
WO2006054830A1 (en) 2006-05-26
CN103524436B (zh) 2015-09-23
US8314100B2 (en) 2012-11-20
EP1819698B1 (de) 2011-02-23
JP2008520653A (ja) 2008-06-19
MX2007005863A (es) 2007-10-19
AU2005307209A1 (en) 2006-05-26
PL1819698T3 (pl) 2011-08-31
EP1819698A1 (de) 2007-08-22
CN103524436A (zh) 2014-01-22
US8598173B2 (en) 2013-12-03
JP6097946B2 (ja) 2017-03-22
CA2587891C (en) 2010-08-31
US20130053390A1 (en) 2013-02-28
AU2005307209B2 (en) 2009-11-19
BRPI0517734A (pt) 2008-10-21
US20080318963A1 (en) 2008-12-25
CA2587891A1 (en) 2006-05-26
DE602005026557D1 (de) 2011-04-07

Similar Documents

Publication Publication Date Title
EA200600892A1 (ru) Новые хинолиновые производные
WO2002055496A8 (en) Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
EA200601350A1 (ru) Азотсодержащие гетероциклические производные и их фармацевтические применения
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
SE0303180D0 (sv) Novel compounds
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
SE0302232D0 (sv) Novel Compounds
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
ATE517882T1 (de) Chinolinderivate
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
DE60315492D1 (de) Medizinisch verwendbare arylethanolamin verbindungen
NO20085060L (no) Triazolpyrazinderivater anvendelige som anti-cancermidler
ATE440834T1 (de) Substituierte arylaminderivate und verwendungsverfahren
TW200640900A (en) 1-(2h)-isoquinolone derivative
CY1112727T1 (el) Παραγωγα κυκλοβουτυλ αμινης βενζοθειαζολης και η χρηση αυτων ως προσδετες των υποδοχεων ισταμινης-3
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
EA200801909A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
MXPA04006033A (es) Dicetopiperacinas sustituidas como antagonistas de oxitocina.
TW200616979A (en) Non-nucleoside reverse transcriptase inhibitors
TW200800946A (en) Substituted piperazines as metabotropic glutamate receptor antagonists
MXPA05010020A (es) Derivados de oxamida.
NO20052730L (no) Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
ATE499366T1 (de) 1-ä(6-substituiertes alkoxychinoxalinyl)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1819698

Country of ref document: EP